J&J drug gets biosimilar competition in Europe By: Business Journals September 10, 2013 at 14:43 PM EDT The European Commission granted marketing approval Tuesday for Inflectra, a treatment for rheumatoid arthritis... Read More >> Related Stocks: Johnson & Johnson